These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1324274

  • 1. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
    van Vliet AA, Hackeng WH, Donker AJ, Meuwissen SG.
    J Hepatol; 1992 May; 15(1-2):40-7. PubMed ID: 1324274
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
    Jolobe OM.
    J Hepatol; 1993 Sep; 19(2):321-2. PubMed ID: 8301072
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].
    Brunkhorst R, Wrenger E, Kühn K, Schmidt FW, Koch K.
    Klin Wochenschr; 1989 Aug 01; 67(15):774-83. PubMed ID: 2671477
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of patients with IVCS and gross oedema and ascites with diuretic combination and ACE-inhibitors: relation to baseline PRA and PAC.
    Van Vliet AA, Kröger R, Dubbelman R, Ten Bokkel-Huinink WW.
    Neth J Med; 1995 Feb 01; 46(2):62-72. PubMed ID: 7885524
    [Abstract] [Full Text] [Related]

  • 8. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A, Angeli P, Caregaro L, Menon F, Sacerdoti D, Merkel C.
    Hepatology; 1991 Aug 01; 14(2):231-6. PubMed ID: 1860680
    [Abstract] [Full Text] [Related]

  • 9. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
    Good JM, Brady AJ, Noormohamed FH, Oakley CM, Cleland JG.
    Circulation; 1994 Jul 01; 90(1):220-4. PubMed ID: 8026000
    [Abstract] [Full Text] [Related]

  • 10. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H, Mutschler E.
    Cardiology; 1994 Jul 01; 84 Suppl 2():87-98. PubMed ID: 7954550
    [Abstract] [Full Text] [Related]

  • 11. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM.
    Hepatology; 1993 Sep 01; 18(3):519-28. PubMed ID: 8395457
    [Abstract] [Full Text] [Related]

  • 12. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
    Jespersen B, Jensen L, Sørensen SS, Pedersen EB.
    Eur J Clin Invest; 1990 Dec 01; 20(6):632-41. PubMed ID: 1964125
    [Abstract] [Full Text] [Related]

  • 13. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V, Bosch J, Casamitjana R, Cabrera J, Rivera F, Rodés J.
    Gut; 1980 Oct 01; 21(10):855-9. PubMed ID: 7439805
    [Abstract] [Full Text] [Related]

  • 14. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A, Codden T, Henry JP, Van Cauter J, Meunier JC, Ligny G.
    Gastroenterol Clin Biol; 2001 Mar 01; 25(3):268-72. PubMed ID: 11395674
    [Abstract] [Full Text] [Related]

  • 15. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
    Gentile S, Bologna E, Terracina D, Angelico M.
    Life Sci; 1994 Mar 01; 54(21):1585-93. PubMed ID: 8196477
    [Abstract] [Full Text] [Related]

  • 16. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Katsaraki A, Tsianos EV.
    Nephrol Dial Transplant; 2005 Aug 01; 20(8):1623-9. PubMed ID: 15886218
    [Abstract] [Full Text] [Related]

  • 17. Acute tolerance to furosemide. Pretreatment with captopril or prazosin does not influence diuresis and natriuresis.
    Kron BG, Sjöström PA, Karlberg BE, Odlind BG.
    Scand J Urol Nephrol; 1994 Dec 01; 28(4):337-44. PubMed ID: 7886407
    [Abstract] [Full Text] [Related]

  • 18. Renin-aldosterone system can respond to furosemide in patients with hyperkalemic hyporeninism.
    Chan R, Sealey JE, Michelis MF, Swan A, Pfaffle AE, Devita MV, Zabetakis PM.
    J Lab Clin Med; 1998 Sep 01; 132(3):229-35. PubMed ID: 9735929
    [Abstract] [Full Text] [Related]

  • 19. [Aldosterone and renin in liver cirrhosis with ascites].
    Vetter H, Vetter W, Beckerhoff R, Glänzer K, Furrer J, Hahn C, Kolloch R, Krück F, Kutz K, Siegenthaler W, Witassek F.
    Schweiz Med Wochenschr; 1977 Dec 03; 107(48):1755-9. PubMed ID: 929137
    [Abstract] [Full Text] [Related]

  • 20. Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril.
    Wilcox CS, Guzman NJ, Mitch WE, Kelly RA, Maroni BJ, Souney PF, Rayment CM, Braun L, Colucci R, Loon NR.
    Kidney Int; 1987 Jan 03; 31(1):135-41. PubMed ID: 3550214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.